Human Liver Models Market Size
Study Period | 2018 - 2028 |
Base Year For Estimation | 2021 |
CAGR | 13.50 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Human Liver Models Market Analysis
The global human liver models market is expected to witness CAGR of 13.5% over the forecast period. The growth is primarily attributed to increasing research and development in healthcare, increasing prevalence of liver diseases and advancements in organ printing technologies. In addition, the increasing focus on developing alternatives for the animal-based models and accuracy in outcomes is projected to boost the market growth. Moreover, increasing prevalence of the non-fatty acid liver disease, alcohol consumption that is leading to liver diseases is anticipated to fuel the market growth over the forecast period. However, the high cost of liver models and issues with the incorporation of liver models into existing workflow are expected to hamper the market growth over the forecast period.
Human Liver Models Market Trends
This section covers the major market trends shaping the Human Liver Models Market according to our research experts:
Liver-on-a-Chip liver models are expected to Grow at Significant Rate
Liver-on-a-Chip is the bioengineered systems that are able to simulate the key features of the fundamental function of the liver. Liver-on -a-chip are simpler and less expensive compared to other models. Furthermore, owing to the growing demand for low-cost alternatives for animal models for drug discovery and development, the segment is projected to grow at significant rates. The increase in initiatives for liver organoids and technological advancements in human organ modelling is anticipated to fuel the overall market growth.
Moreover, increasing liver infections and use of liver models in the development of many drugs is expected to boost the market growth over the forecast period. According to Center for Disease Control and Prevention (CDC), each year in the United States, about 21,000 men and 8,000 women get liver cancer, and about 16,000 men and 8,000 women die from the disease. Also, the increase in consumption of the alcohol around the world is leading to the liver diseases increasing the demand for liver models.
North America is Expected to have Significant Market Share
North America and Europe are expected to have the majority of the market share owing to increasing R&D expenditure, innovation in the organ models and adoption of innovative potential therapies in the region. Moreover, increasing prevalence of liver diseases coupled with the presence of key market players in the region is anticipated to boost the market growth over the forecast period. Asia Pacific region is expected to expand its share due to increasing R&D investments in developing countries of the region. Moreover, developing healthcare infrastructure and companies focus on the development of new therapeutics expected to bolster regional growth.
Human Liver Models Industry Overview
Global human liver models market is moderately consolidated and competitive. Market players are focusing on product innovations, new product launches and regional expansions to increase their market share. The key market players operating in the market include Emulate, Inc., InSphero, BioIVT, Organovo Holdings Inc., and Mimetas among others.
Human Liver Models Market Leaders
-
Emulate, Inc.
-
InSphero
-
BioIVT
-
Organovo Holdings Inc.
-
Mimetas
*Disclaimer: Major Players sorted in no particular order
Human Liver Models Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Increasing Prevalence of Chronic Diseases and Geriatric Population
-
4.2.2 Increasing Demand For Technologically Advanced Stretchers
-
-
4.3 Market Restraints
-
4.3.1 High Cost of Specialized Stretchers
-
4.3.2 Growing Adoption of Home Healthcare
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Product Type
-
5.1.1 2D Models
-
5.1.2 3D Models
-
5.1.3 Liver-on-a-Chip
-
5.1.4 Others
-
-
5.2 Application
-
5.2.1 Eduction
-
5.2.2 Drug Discovery
-
5.2.3 Others
-
-
5.3 Geography
-
5.3.1 North America
-
5.3.1.1 United States
-
5.3.1.2 Canada
-
5.3.1.3 Mexico
-
-
5.3.2 Europe
-
5.3.2.1 Germany
-
5.3.2.2 United Kingdom
-
5.3.2.3 France
-
5.3.2.4 Italy
-
5.3.2.5 Spain
-
5.3.2.6 Rest of Europe
-
-
5.3.3 Asia-Pacific
-
5.3.3.1 China
-
5.3.3.2 Japan
-
5.3.3.3 India
-
5.3.3.4 Australia
-
5.3.3.5 South Korea
-
5.3.3.6 Rest of Asia-Pacific
-
-
5.3.4 Middle-East and Africa
-
5.3.4.1 GCC
-
5.3.4.2 South Africa
-
5.3.4.3 Rest of Middle-East and Africa
-
-
5.3.5 South America
-
5.3.5.1 Brazil
-
5.3.5.2 Argentina
-
5.3.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Organovo Holdings Inc.
-
6.1.2 BioIVT
-
6.1.3 InSphero
-
6.1.4 Emulate, Inc.
-
6.1.5 Mimetas
-
6.1.6 CN Bio
-
6.1.7 Cyfuse Biomedical K.K.
-
6.1.8 HuREL Corporation
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Human Liver Models Industry Segmentation
Liver is an important organ that performs vital body functions such as synthesis of blood clotting factors, bile production, protein production and detoxification. Human liver models are used to study the toxicity of the drug and enable understanding of the effect of drugs and the progression of liver disease.
By Product Type | |
2D Models | |
3D Models | |
Liver-on-a-Chip | |
Others |
Application | |
Eduction | |
Drug Discovery | |
Others |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Human Liver Models Market Research FAQs
What is the current Human Liver Models Market size?
The Human Liver Models Market is projected to register a CAGR of 13.5% during the forecast period (2023-2028).
Who are the key players in Human Liver Models Market?
Emulate, Inc., InSphero, BioIVT, Organovo Holdings Inc. and Mimetas are the major companies operating in the Human Liver Models Market.
Which is the fastest growing region in Human Liver Models Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2023-2028).
Which region has the biggest share in Human Liver Models Market?
In 2023, the North America accounts for the largest market share in the Human Liver Models Market.
Human Liver Models Industry Report
Statistics for the 2023 Human Liver Models market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Human Liver Models analysis includes a market forecast outlook to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.